Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 581 | 2,161 | 3,590 | 6,351 | 11,803 |
| Gross Profit | 581 | 2,161 | 3,590 | 6,351 | 11,803 |
| Operating Expenses | 7,983 | 10,021 | 11,397 | 12,894 | 18,510 |
| Operating Income | -7,402 | -7,860 | -7,807 | -6,543 | -6,707 |
| Interest Expense | 92 | 88 | 71 | 71 | 72 |
| Other Income | 141 | 99 | 802 | 1,746 | 7,857 |
| Pre-tax Income | -7,354 | -7,849 | -7,076 | -4,868 | 1,078 |
| Income Tax | N/A | 26 | N/A | -92 | 92 |
| Net Income Continuous | -7,354 | -7,875 | -7,076 | -4,776 | 986 |
| Net Income | $-7,354 | $-7,875 | $-7,076 | $-4,776 | $986 |
| EPS Basic Total Ops | -1.46 | -1.81 | -1.60 | -1.10 | 0.20 |
| EPS Basic Continuous Ops | -1.46 | -1.78 | -1.64 | -1.11 | 0.23 |
| EPS Diluted Total Ops | -1.46 | -1.81 | -1.60 | -1.10 | 0.20 |
| EPS Diluted Continuous Ops | -1.46 | -1.77 | -1.64 | -1.11 | 0.22 |
| EBITDA(a) | $-6,479 | $-6,937 | $-6,897 | $-5,762 | $-6,030 |